WS04.05 Sustained Improvement in Abdominal Symptoms Measured by the CFAbd-Score over 2 Years of Treatment with Elexacaftor/tezacaftor/ivacaftor in People with CF Aged ≥12 Years: Results from the RECOVER Study
Journal of Cystic Fibrosis(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined